After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. The current market capitalization of Castle Biosciences Inc is $589.57M. A total of 0.5 million shares were traded on the day, compared to an average of 454.66K shares.
In the most recent transaction, Derek Maetzold bought 16,932 shares of CSTL for 20.35 per share on Jun 27 ’25. In a previous transaction on Apr 21 ’25, MAETZOLD DEREK J sold 4,408 shares at 21.52 per share. CSTL shares that Pres. & Chief Exec. Officer owns now total 4,275.
Among the insiders who sold shares, MAETZOLD DEREK J disposed of 1,236 shares on Apr 21 ’25 at a per-share price of $21.52. This resulted in the Pres. & Chief Exec. Officer holding 74,627 shares of CSTL after the transaction. In another insider transaction, MAETZOLD DEREK J sold 3,647 shares at $20.22 per share on Apr 09 ’25. Company shares held by the Pres. & Chief Exec. Officer now total 4,440.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CSTL has a high of $35.84 and a low of $15.45.
As of this writing, CSTL has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.36 per share and a lower estimate of -$0.64.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CSTL’s latest balance sheet shows that the firm has $329.63M in Cash & Short Term Investments as of fiscal 2021. There were $8.20M in debt and $24.89M in liabilities at the time. Its Book Value Per Share was $15.26, while its Total Shareholder’s Equity was $411.74M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CSTL is Buy with a score of 5.00.
